[Ovid] GLP-1 receptor agonist每SGLT-2 inhibitor combination and risk of major adverse liver and cardiovascular outcomes in adults with MASLD and type 2 diabetes

 Close Closed
Biswojit Post time 4 day(s) ago | Show all posts |Read mode
Reward10points

journalㄩHepatology

AuthorsㄩXianhua Mao; Hong Fan; Man-Fung Yuen; Ramsey Cheung; Wai-Kay Seto; Mindie H. Nguyen

Published dateㄩ--

DOIㄩ10.1097/hep.0000000000001771

PDF linkㄩhttps://journals.lww.com/10.1097/HEP.0000000000001771

Article linkㄩhttps://doi.org/10.1097/hep.0000000000001771

Article SourceㄩOvid Technologies (Wolters Kluwer Health)


Remarkㄩ
Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Return to the list